Application of median lethal concentration (LC(50)) of pathogenic microorganisms and their antigens in vaccine development

病原微生物及其抗原的半数致死浓度(LC(50))在疫苗研发中的应用

阅读:2

Abstract

OBJECTIVE: Lack of ideal mathematical models to qualify and quantify both pathogenicity, and virulence is a dreadful setback in development of new antimicrobials and vaccines against resistance pathogenic microorganisms. Hence, the modified arithmetical formula of Reed and Muench has been integrated with other formulas and used to determine bacterial colony forming unit/viral concentration, virulence and immunogenicity. RESULTS: Microorganisms' antigens tested are Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeruginosa in mice and rat, Edwardsiella ictaluri, Aeromonas hydrophila, Aeromonas veronii in fish, New Castle Disease virus in chicken, Sheep Pox virus, Foot-and-Mouth Disease virus and Hepatitis A virus in vitro, respectively. The LC(50)s for the pathogens using different routes of administrations are 1.93 × 10(3)(sheep poxvirus) and 1.75 × 10(10) for Staphylococcus aureus (ATCC29213) in rat, respectively. Titer index (TI) equals N log(10) LC(50) and provides protection against lethal dose in graded fashion which translates to protection index. N is the number of vaccine dose that could neutralize the LC(50). Hence, parasite inoculum of 10(3) to 10(11) may be used as basis for determination of LC(50) and median bacterial concentrations (BC(50)).Pathogenic dose for immune stimulation should be sought at concentration about LC(10).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。